Br J Sports Med. Published Online First: 29 January 2007. doi:10.1136/bjsm.2006.032516
Leader |
Is there a link between malignant hyperthermia and exertional heat illness?
1 Malignant Hyperthermia Investigation Unit , St James's University Hospital, Leeds, United Kingdom
* To whom correspondence should be addressed. E-mail: p.m.hopkins{at}leeds.ac.uk.
Accepted 6 January 2007
Abstract
No abstract: first paragraph: Malignant hyperthermia is a relatively rare pharmacogenetic disorder inherited in an autosomal dominant fashion1. It is triggered in previously healthy susceptible individuals by exposure to potent inhalational anaesthetic agents and the muscle relaxant suxamethonium (succinylcholine). The clinical features of a malignant hyperthermia reaction have many similarities to those of heat illness2. These include a mixed respiratory and metabolic acidosis, tachycardia, rhabdomyolysis and muscle rigidity with progressive hyperthermia. The condition acquired its name because of the high mortality of the early cases.
Key Words: dantrolene, heat illness, heat stroke, exercise, heat stroke, pathophysiology, malignant hyperthermia
eLetters:
Read all eLetters
- Royal Navy Heat Illness Clinic
- Daniel G Roiz de Sa, et al.
- BJSM Online, 31 May 2007 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
